Support, Insights, News, and More.

Treating depression isn’t easy. But knowledge is power. That’s why the makers of PRISTIQ developed a free program that offers information and support to people taking PRISTIQ. By providing you with materials to help you better understand depression, and specific steps you can take toward a healthy lifestyle, A New Day^™ may help you feel empowered as you move toward gaining control of your depression.

Enroll today and over the next few months you’ll receive:

The A New Day mini-magazines — Science: Understanding Depression and Your Medication and Lifestyle: Healthy Living Tips You Can Use Every Day. In these magazines, you'll find articles filled with helpful information and unique insights about depression, what to expect from PRISTIQ, and tips for living a healthy lifestyle.
Periodic e-mails offering additional information and support.
A simple-to-use Progress Tracker, to help you track your response to treatment with PRISTIQ and have more informed conversations with your health care professional about your treatment plan.
The Insights from A New Day CD includes information about depression and PRISTIQ from a noted psychiatrist along with insights from people who have faced many of the same depression obstacles you may be struggling with.


Enroll today in *A New Day*, a free program of information and support designed exclusively for people taking PRISTIQ. Answer the following question and click "Continue" to begin the registration process:
Do you currently have a prescription for PRISTIQ?
Yes No

PRISTIQ Important Safety Information

PRISTIQ^® (desvenlafaxine) is approved for the treatment of major depressive disorder in adults.

Suicidality and Antidepressant Drugs

Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, teens, and young adults. Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide. Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior. PRISTIQ is not approved for use in children under 18.

People taking MAOIs should not take PRISTIQ.
All patients taking antidepressants should be observed closely for signs that their condition is getting worse or that they are becoming suicidal. This is very important when an antidepressant is started or when the dose is changed. Patients should be watched for becoming agitated, irritable, hostile, aggressive, impulsive, or restless. These symptoms should be reported to the patient’s health care professional right away.
Tell your health care professional about all prescription and over-the-counter medications you are taking or plan to take, including:
- Medicines to treat migraines or mood disorders, to avoid a potentially life-threatening condition
- Aspirin, NSAID pain relievers, or blood thinners because they may increase the risk of bleeding
PRISTIQ may cause or make some conditions worse, so tell your health care professional about all your medical conditions, including if you:
- Have high blood pressure. Your blood pressure should be controlled before you start taking PRISTIQ and monitored regularly
- Have heart problems, high cholesterol or triglyceride levels, or a history of stroke
- Have glaucoma or increased eye pressure
- Have kidney or liver problems
- Have or had mania, bipolar disorder, or seizures or convulsions
- Have low sodium levels in your blood
- Are nursing, pregnant, or plan to become pregnant
Discontinuation symptoms may occur when stopping PRISTIQ, especially when therapy is stopped suddenly. Talk to your health care professional before you stop taking or reduce the dose of PRISTIQ.
Until you see how PRISTIQ affects you, be careful driving a car or operating machinery. Avoid drinking alcohol while taking PRISTIQ.
Side effects when taking PRISTIQ 50 mg may include nausea, dizziness, sweating, constipation, and decreased appetite.

260537-01

Wyeth is now a part of Pfizer Inc. The merger of local Wyeth and Pfizer entities may
be pending in various jurisdictions and is subject to completion of various local legal
and regulatory obligations. To learn more, please visit www.pfizer.com. 260149-01